LTRN Q4 2024 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$31M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$51,224

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-0.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$285,499

Balance Sheet

Total Assets

$26M

Total Liabilities

$4M

Stockholders' Equity

$21M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$51,224	-$44,317	-15.6%
Operating Income	-$6M	-$5M	-20.9%
Net Income	-$6M	-$4M	-40.4%